Circulating Cytokines and Growth Factors in Pediatric Pulmonary Hypertension
Background. Management of pediatric pulmonary hypertension (PH) remains challenging. We have assessed a panel of circulating proteins in children with PH to investigate their value as predictive and/or prognostic biomarkers. From these determinations, we aim to develop a practical, noninvasive tool...
Saved in:
Main Authors: | Mark Duncan, Brandie D. Wagner, Keri Murray, Jenna Allen, Kelley Colvin, Frank J. Accurso, D. Dunbar Ivy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2012/143428 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Cytokines in Young Pediatric Patients with Congenital Cardiac Shunts and Altered Pulmonary Hemodynamics
by: Leína Zorzanelli, et al.
Published: (2016-01-01) -
Age influences the circulating immune profile in pediatric sepsis
by: Grace Fisler, et al.
Published: (2025-01-01) -
Pulmonary Hypertension in Pulmonary Langerhans Cell Granulomatosis
by: Matthias Held, et al.
Published: (2012-01-01) -
Information Experiences and Needs in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
by: Bodil Ivarsson, et al.
Published: (2014-01-01) -
Canadian Cardiovascular Society and Canadian Thoracic Society Position Statement on Pulmonary Arterial Hypertension
by: David Langleben, et al.
Published: (2005-01-01)